# Genetic Basis for Variation in the Renal Elimination of Metformin

> **NCT00187720** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 23 (actual)

## Conditions studied

- Other Conditions That May Be A Focus of Clinical Attention

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00187720
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187720, "Genetic Basis for Variation in the Renal Elimination of Metformin". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00187720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*